MDxHealth SA (MDXH)

NASDAQ: MDXH · IEX Real-Time Price · USD
2.590
+0.130 (5.28%)
At close: Mar 28, 2024, 4:00 PM
2.580
-0.010 (-0.39%)
After-hours: Mar 28, 2024, 6:01 PM EDT

Total Valuation

MDxHealth has a market cap or net worth of $70.68 million. The enterprise value is $155.72 million.

Market Cap 70.68M
Enterprise Value 155.72M

Important Dates

The last earnings date was Wednesday, March 6, 2024, after market close.

Earnings Date Mar 6, 2024
Ex-Dividend Date n/a

Share Statistics

MDxHealth has 27.29 million shares outstanding.

Shares Outstanding 27.29M
Owned by Insiders (%) 2.63%
Owned by Institutions (%) 40.30%
Float 17.00M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.01
Forward PS 0.87
PB Ratio 9.81
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.22
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.96, with a Debt / Equity ratio of 14.90.

Current Ratio 1.96
Quick Ratio 1.71
Debt / Equity 14.90
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.73

Financial Efficiency

Return on equity (ROE) is -192.90% and return on invested capital (ROIC) is -23.84%.

Return on Equity (ROE) -192.90%
Return on Assets (ROA) -30.90%
Return on Capital (ROIC) -23.84%
Revenue Per Employee $278,544
Profits Per Employee -$171,032
Employee Count 252
Asset Turnover 0.50
Inventory Turnover 10.29

Taxes

In the past 12 months, MDxHealth has paid $1,000 in taxes.

Income Tax 1,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -14.52% in the last 52 weeks. The beta is -379,681.88, so MDxHealth's price volatility has been lower than the market average.

Beta (1Y) -379,681.88
52-Week Price Change -14.52%
50-Day Moving Average 3.38
200-Day Moving Average 3.29
Relative Strength Index (RSI) 35.62
Average Volume (30 Days) 73,681

Short Selling Information

Short Interest 23,350
Short Previous Month 20,211
Short % of Shares Out 0.13%
Short % of Float n/a
Short Ratio (days to cover) 0.32

Income Statement

In the last 12 months, MDxHealth had revenue of $70.19 million and -$43.10 million in losses. Loss per share was -$16.60.

Revenue 70.19M
Gross Profit 43.93M
Operating Income -27.33M
Pretax Income -43.10M
Net Income -43.10M
EBITDA -20.47M
EBIT -27.33M
Loss Per Share -$16.60
Full Income Statement

Balance Sheet

The company has $22.38 million in cash and $107.42 million in debt, giving a net cash position of -$85.04 million or -$3.12 per share.

Cash & Cash Equivalents 22.38M
Total Debt 107.42M
Net Cash -85.04M
Net Cash Per Share -$3.12
Equity / Book Value 7.21M
Book Value Per Share 0.26
Working Capital 18.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.50 million and capital expenditures -$2.75 million, giving a free cash flow of -$24.24 million.

Operating Cash Flow -21.50M
Capital Expenditures -2.75M
Free Cash Flow -24.24M
FCF Per Share -$8.97
Full Cash Flow Statement

Margins

Gross margin is 62.58%, with operating and profit margins of -38.93% and -61.40%.

Gross Margin 62.58%
Operating Margin -38.93%
Pretax Margin -61.40%
Profit Margin -61.40%
EBITDA Margin -29.16%
EBIT Margin -38.93%
FCF Margin -34.54%

Dividends & Yields

MDxHealth does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -73.36%
Shareholder Yield -73.36%
Earnings Yield -60.98%
FCF Yield -34.30%

Analyst Forecast

The average price target for MDxHealth is $7.33, which is 183.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.33
Price Target Difference 183.01%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 16.65%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.

Last Split Date Nov 14, 2023
Split Type Reverse
Split Ratio 1:10

Scores

MDxHealth has an Altman Z-Score of -3.23 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.23
Piotroski F-Score 4